Approach Considerations
No antidote to riot control agents (RCAs) exists, so treatment is symptomatic and supportive. Treatment measures for RCA exposure include the following:
-
- Remove clothes if clothing has been contaminated by RCAs.
- Ocular exposures initially require thorough eye decontamination. Flushing the eyes with water or saline for 10–20 min is the most often recommended for initial decontamination.
- Dermal exposures require simple soap and water decontamination for the most part. [1] Potential decontamination agents have been studied, including aluminium hydroxide/magnesium hydroxide antacid, 2% lidocaine gel, milk, and baby shampoo, but none showed better efficacy than water. [1, 21]
Prehospital Care
Most people exposed to irritants do not seek medical care, and effects are self-limited. When persons seek care, first withdraw them from exposure. Responders should wear appropriate personal protective equipment (PPE). Decontamination should then proceed as follows:
- Remove contaminated external clothing.
- Acceptable decontaminating solutions are water or soap and water.
- Do not use hypochlorite; this relatively caustic solution may worsen the condition of skin injuries already suffered from exposure to irritants.
- Thoroughly flush eyes with water or saline; Patents may require a topical anesthetic to enable them to open their eyelids sufficiently for effective irrigation. Contact lenses should be removed before flushing.
- Devote specific attention to very young, infirm, and elderly patients, since their responses to these agents may be significant.
- Bronchodilator therapy may be used for those with postexposure bronchospasm.
- Warn patients that the pain worsens during decontamination.
- In patients with severe respiratory compromise, aggressive airway control, including invasive measures, may be required.
Emergency Department Care
Initiate or continue care in the emergency department (ED) as follows:
- ED personnel should don proper personal protection equipment (PPE) to minimize accidental exposure.
- A site should be established for the disrobing and general decontamination (see Prehospital Care) of the patients.
- Flush the eyes of patients with eye complaints with normal saline or water to remove any particulate matter before fluorescein slit lamp examination for corneal abrasion.
- Treat more severe injuries, which occur in fewer than 1% of patients, in the usual fashion.
- Corneal abrasions can be treated with local antibiotics, oral analgesics, and close follow-up care.
- The rare eye foreign body may merit ophthalmologic consultation.
-
- Treat bronchospasm with bronchodilators.
- Topical/parenteral analgesia as needed.
Most patients with irritant exposure can safely be discharged from the ED, as the few reported dangerous effects occur rapidly.The rare patient with significant respiratory damage may require oxygen supplementation, aggressive bronchodilator therapy (if bronchospasm is present), and admission to the hospital, possibly a critical care unit.
Characteristically, hospital admission for extended medical care is not indicated. Should hospitalization be required, consider alternative diagnoses.
Medical Care
Victims should be made aware that initial symptoms may be minimal or that there may even be a latent period. Should any clinical deterioration occur the patient should be re-evaluated.
Medical follow-up is indicated for a minority of patients, including those with any of the following:
- Very young age
- Advanced age
- Comorbidities
- Significant dermal injuries
- Prolonged respiratory difficulties
Consultations
Consultations with one or more of the following may be indicated:
- Ophthalmologist
- Burn specialist
- Mental health specialist
- Pulmonologist
Diet
No restrictions.
Activity
As tolerated.
Long-Term Monitoring
Consider the following in long-term monitoring:
- Opthalmologist consultation with possible significant damage to the eyes
- Pulmonologist consultation should there be any long-term respiratory complications
- Mental health
- Burn care
Schep LJ, Slaughter RJ, McBride DI. Riot Control Agents: The tear gases CN, CS, and OC - a medical review. J R Army Med Corp. 6/2015. 161:94-99. [Medline].
Dimitroglou Y, Rachiotis G, Hadjichristodoulou C. Exposure to the riot control agent CS and potential health effects: a systematic review of the evidence. Int J Environ Res Public Health. 2015 Jan 27. 12 (2):1397-411. [Medline].
Centers for Disease Control and Prevention. Riot Control Agent Poisonings; Toxic Syndrome Description. CDC.gov. Available at https://emergency.cdc.gov/agent/riotcontrol/agentpoisoning.asp. November 18, 2015; Accessed: May 24, 2018.
The National Institute for Occupational Safety and Health. Chloroacetophenone (CN): Riot Control/Tear Agent. CDC.gov. Available at https://www.cdc.gov/niosh/ershdb/emergencyresponsecard_29750033.html. November 9, 2017; Accessed: April 11, 2018.
National Institute for Occupational Safety and Health. Chloropicrin (PS): Lung Damaging Agent. CDC.gov. Available at https://www.cdc.gov/niosh/ershdb/emergencyresponsecard_29750034.html. November 9, 2017; Accessed: April 11, 2018.
Centers for Disease Control and Prevention. Facts About Riot Control Agents. CDC.gov. Available at https://emergency.cdc.gov/agent/riotcontrol/factsheet.asp. March 21, 2013; Accessed: April 11, 2018.
Committee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies, National Research Council. Tear Gas (CS). 2014 Mar 21. [Medline]. [Full Text].
[Guideline] Warden CR. Respiratory agents: irritant gases, riot control agents, incapacitants, and caustics. Crit Care Clin. 2005 Oct. 21(4):719-37, vi. [Medline].
Karagama YG, Newton JR, Newbegin CJ. Short-term and long-term physical effects of exposure to CS spray. J R Soc Med. 2003 Apr. 96(4):172-4. [Medline].
Yeung MF, Tang WY. Clinicopathological effects of pepper (oleoresin capsicum) spray. Hong Kong Med J. 2015 Dec. 21 (6):542-52. [Medline]. [Full Text].
Pesonen M, Vahakangas K, Halme M, et al. Capsaicinoids, chloropicrin and sulfur mustard: possibilities for exposure biomarkers. Front Pharmacol. 2010. 1:140. [Medline]. [Full Text].
Hankin SM, Ramsay CN. Investigation of accidental secondary exposure to CS agent. Clin Toxicol (Phila). 2007 May. 45(4):409-11. [Medline].
Brone B, Peeters PJ, Marrannes R, et al. Tear gasses CN, CR, and CS are potent activators of the human TRPA1 receptor. Toxicol Appl Pharmacol. Sep 2008. 231(2):150-6. [Medline].
Rothenberg C, Achanta S, Svendsen ER, Jordt SE. Tear gas: an epidemiological and mechanistic reassessment. Ann N Y Acad Sci. 2016 Aug. 1378 (1):96-107. [Medline]. [Full Text].
Haar RJ, Iacopino V, Ranadive N, Weiser SD, Dandu M. Health impacts of chemical irritants used for crowd control: a systematic review of the injuries and deaths caused by tear gas and pepper spray. BMC Public Health. 2017 Oct 19. 17 (1):831. [Medline]. [Full Text].
Toprak S, Ersoy G, Hart J, Clevestig P. The pathology of lethal exposure to the riot control agents: Towards a forensic-based methodology for determining misuse. J Forensic Legal Med. 2015. 29:36-42. [Medline].
Schep LJ, Slaughter RJ, McBride DI. Riot control agents: the tear gases CN, CS and OC-a medical review. J R Army Med Corps. 2015 Jun. 161 (2):94-9. [Medline]. [Full Text].
Watson K, Rycroft R. Unintended cutaneous reactions to CS spray. Contact Dermatitis. 2005 Jul. 53(1):9-13. [Medline].
Billmire DF, Vinocur C, Ginda M, Robinson NB, Panitch H, Friss H. Pepper-spray-induced respiratory failure treated with extracorporeal membrane oxygenation. Pediatrics. 1996 Nov. 98(5):961-3. [Medline].
Shen S. Riot-control agent attack. Ciottone GR, Anderson PD, Auf Der Heide E, Darling RG, Jacoby I, Noji E, Suner S, eds. Disaster Medicine. 3rd ed. Philadelphia, PA: Mosby/Elsevier; 2006. Chap 98, 593-595.
Stopyra JP, Winslow JE 3rd, Johnson JC 3rd, Hill KD, Bozeman WP. Baby Shampoo to Relieve the Discomfort of Tear Gas and Pepper Spray Exposure: A Randomized Controlled Trial. West J Emerg Med. 2018 Mar. 19 (2):294-300. [Medline]. [Full Text].
Pitschmann V. Overall view of chemical and biochemical weapons. Toxins (Basel). 2014 Jun 4. 6 (6):1761-84. [Medline]. [Full Text].
Tables
-
- Overview
- Presentation
- DDx
- Workup
- Treatment
- Medication
- References